| Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ... Science 359 (6371), 91-97, 2018 | 4355 | 2018 |
| Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer … DH Henry, L Costa, F Goldwasser, V Hirsh, V Hungria, J Prausova, ... J Clin Oncol 29 (9), 1125-1132, 2011 | 1408 | 2011 |
| Prevalence of malnutrition and current use of nutrition support in patients with cancer X Hébuterne, E Lemarié, M Michallet, CB de Montreuil, SM Schneider, ... Journal of Parenteral and Enteral Nutrition 38 (2), 196-204, 2014 | 860 | 2014 |
| Controlling tumor growth by modulating endogenous production of reactive oxygen species A Laurent, C Nicco, C Chéreau, C Goulvestre, J Alexandre, A Alves, ... Cancer research 65 (3), 948-956, 2005 | 593 | 2005 |
| Management of hypertension in angiogenesis inhibitor-treated patients H Izzedine, S Ederhy, F Goldwasser, JC Soria, G Milano, A Cohen, ... Annals of oncology 20 (5), 807-815, 2009 | 428 | 2009 |
| Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel‐induced cancer cell death both in vitro and in vivo J Alexandre, F Batteux, C Nicco, C Chéreau, A Laurent, L Guillevin, ... International journal of cancer 119 (1), 41-48, 2006 | 387 | 2006 |
| VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management H Izzedine, C Massard, JP Spano, F Goldwasser, D Khayat, JC Soria European Journal of Cancer 46 (2), 439-448, 2010 | 360 | 2010 |
| Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma O Mir, R Coriat, B Blanchet, JP Durand, P Boudou-Rouquette, J Michels, ... PloS one 7 (5), e37563, 2012 | 325 | 2012 |
| TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma J Biton, A Mansuet-Lupo, N Pécuchet, M Alifano, H Ouakrim, J Arrondeau, ... Clinical Cancer Research 24 (22), 5710-5723, 2018 | 280 | 2018 |
| Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports E Wasserman, A Myara, F Lokiec, F Goldwasser, F Trivin, M Mahjoubi, ... Annals of Oncology 8 (10), 1049-1051, 1997 | 267 | 1997 |
| Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients O Huillard, O Mir, M Peyromaure, C Tlemsani, J Giroux, ... British journal of cancer 108 (5), 1034-1041, 2013 | 256 | 2013 |
| Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer L Derosa, B Routy, AM Thomas, V Iebba, G Zalcman, S Friard, J Mazieres, ... Nature medicine 28 (2), 315-324, 2022 | 254 | 2022 |
| Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial JP Durand, G Deplanque, V Montheil, JM Gornet, F Scotte, O Mir, ... Annals of Oncology 23 (1), 200-205, 2012 | 254 | 2012 |
| Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir J Alexandre, C Nicco, C Chéreau, A Laurent, B Weill, F Goldwasser, ... Journal of the National Cancer Institute 98 (4), 236-244, 2006 | 238 | 2006 |
| Anthracyclines during pregnancy: embryo–fetal outcome in 160 patients N Germann, F Goffinet, F Goldwasser Annals of oncology 15 (1), 146-150, 2004 | 227 | 2004 |
| Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients—preliminary evidence of activity S Delaloge, A Yovine, A Taamma, M Riofrio, E Brain, E Raymond, P Cottu, ... Journal of Clinical Oncology 19 (5), 1248-1255, 2001 | 219 | 2001 |
| Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen F Goldwasser, I Bae, M Valenti, K Torres, Y Pommier Cancer research 55 (10), 2116-2121, 1995 | 218 | 1995 |
| Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo R Coriat, C Nicco, C Chéreau, O Mir, J Alexandre, S Ropert, B Weill, ... Molecular cancer therapeutics 11 (10), 2284-2293, 2012 | 213 | 2012 |
| Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy … O Soubrane, A Brouquet, S Zalinski, B Terris, C Brézault, V Mallet, ... Annals of surgery 251 (3), 454-460, 2010 | 211 | 2010 |
| Correlations between S and G2 Arrest and the Cytotoxicity of Camptothecin in Human Colon Carcinoma Cells F Goldwasser, T Shimizu, J Jackman, Y Hoki, PM O'Connor, KW Kohn, ... Cancer research 56 (19), 4430-4437, 1996 | 210 | 1996 |
